ALPS Medical Breakthroughs ETF
SBIO
31 hedge funds and large institutions have $31M invested in ALPS Medical Breakthroughs ETF in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 4 closing their positions.
95% more capital invested
Capital invested by funds: $15.9M → $31M (+$15.1M)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
7.47% more ownership
Funds ownership: 11.17% → 18.64% (+7.5%)
7% more funds holding
Funds holding: 29 → 31 (+2)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $747K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$14.1M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.42M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$512K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$344K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$221K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Davenport & Co
Richmond,
Virginia
|
-$1.19M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.16M |
| 3 |
Jane Street
New York
|
-$1.09M |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$585K |
| 5 |
ACM
Aviance Capital Management
Sarasota,
Florida
|
-$291K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
26
Ladenburg Thalmann Financial Services
Miami,
Florida
| $31K | -$5.49K | -179 | -16% |
|
|
MPWT
27
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $8.51K | +$8.21K | +268 | New |
|
|
GT
28
Glenmede Trust
Philadelphia,
Pennsylvania
| $6K | – | – | – |
|
|
CG
29
Colony Group
Boston,
Massachusetts
| $6K | +$6.13K | +200 | New |
|
30
Citigroup
New York
| $3K | +$3.06K | +100 | New |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $72 | -$120K | -3,912 | -63% |
|
|
DC
32
Davenport & Co
Richmond,
Virginia
| – | -$1.19M | -42,587 | Closed |
|
|
ACM
33
Aviance Capital Management
Sarasota,
Florida
| – | -$291K | -10,423 | Closed |
|
34
JP Morgan Chase
New York
| – | -$220K | -7,910 | Closed |
|
|
RIA
35
Regal Investment Advisors
Kentwood,
Michigan
| – | -$5K | -185 | Closed |
|
SBIO Hedge Fund Activity: Q4 2015 in Review
31 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2015, worth a combined $31M — up 95% from $15.9M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SBIO positions and 4 closed out — a net gain of 2 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was LPL Financial, adding an estimated $14.1M. The largest seller was Davenport & Co, exiting entirely with an estimated $1.19M sold.
- 31 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2015, up from 29 in Q3 2015.
- Funds reported $31M of ALPS Medical Breakthroughs ETF stock for Q4 2015, up 95% quarter-over-quarter.
- 6 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2015 and 4 closed out, a net change of +2 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q4 2015 was LPL Financial, an estimated $14.1M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q4 2015 was Davenport & Co, an estimated $1.19M sold.
Based on aggregated 13F filings for Q4 2015.